Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05615831 |
Other study ID # |
2021-124 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
May 1, 2022 |
Est. completion date |
November 22, 2023 |
Study information
Verified date |
December 2023 |
Source |
University of New Brunswick |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The primary objective is to investigate whether six weeks of resistance training, in
combination with blood flow restriction, produces a different adaptation in fat-free mass
between males and females that are not physically active. The secondary objective is to
compare changes in physical function, physical performance, and blood biomarkers between
males and females following resistance training and blood flow restriction.
Description:
Previous studies indicated a reduced workload (i.e., lifting lighter weight) combined with
blood flow restriction leads to increased fat-free mass and muscle strength. However, females
have been underrepresented in the blood flow restriction literature. Therefore, no study has
investigated whether males and females of different age groups have different adaptations in
fat-free mass, muscle strength, and performance outcomes following resistance training using
blood flow restriction.
The primary objective will be to investigate sex differences in fat-free mass following six
weeks of resistance training combined with blood flow restriction in young and older adults.
The secondary objective is to investigate sex differences in muscle strength, physical
performance, and blood biomarkers between males and females following resistance training and
blood flow restriction.
Briefly, participants between 19-30 years and 65 years and older will be recruited to
participate in this study. Participants will present to the laboratory for two baseline
testing visits interspersed with a minimum of four days. The first testing visit will include
a variety of questionnaires, a blood draw, lipid and glucose, a dual-energy x-ray
absorptiometry scan, anthropometrics, and a submaximal VO2. The second visit will include
several physical function tests, such as the short physical performance battery and the
Y-balance test, as well as a high-intensity isokinetic fatigue test using isokinetic
dynamometry and 1-repetition maximum testing.
Upon completion of baseline testing, participants are enrolled in the exercise program. The
first exercise session includes a blood draw before and immediately after the training
session. This procedure will be duplicated at the final exercise session at the end of the
six weeks.
Participants' full occlusion will be estimated using the formula developed by Loenneke et al.
(2015). Then each participant's occlusion will be set at 60% of each individual's total limb
occlusion. This will be used in combination with the following exercises incline chest press,
seated row, leg press, knee extension, and knee flexion performed at 30% of 1RM. The protocol
is as follows: 30 repetitions followed by three sets of 15 repetitions for a total of four
sets and 75 repetitions per exercise. There will be a one-minute recovery between sets where
the cuffs remain inflated and a four-minute recovery between exercises where the cuffs will
be deflated.
Following the completion of the six weeks of exercise, participants will again present to the
laboratory for two follow-up visits similar to the first two baseline visits.